CompletedNot Applicable

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)

Denmark21 participantsStarted 2011-07

Plain-language summary

Purpose: The purpose of the study is to examine if treatment with liothyronine increases left ventricular ejection fraction (LVEF) in patients with stable, chronic heart failure.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with stable, chronic systolic heart failure * T3 ≤1.4 nmol/l in two blood samples, TSH is to be normal * LVEF ≤ 45 % on prior echocardiography Exclusion Criteria: * Established thyroid illness * Atrial fibrillation/flutter * More than 20% ventricular extrasystoles * Severe chronic obstructive lung disorder * Pregnancy. Pregnancy testing will be done for fertile women * Age \< 18 years

What they're measuring

left ventricle ejection fraction

Timeframe: 3 months

Trial details

NCT IDNCT01481402

SponsorJens Faber

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-02

View on ClinicalTrials.gov More Heart Failure trials